Halozyme Therapeutics (HALO) EBT Margin (QoQ) (2010 - 2026)

Halozyme Therapeutics (HALO) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Halozyme Therapeutics 8.24 Bn 7.92 Bn 297.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,019.00
Dec 31, 2025 -8,413.00
Sep 30, 2025 -111.00
Jun 30, 2025 862.00
Mar 31, 2025 -550.00
Dec 31, 2024 287.00
Sep 30, 2024 604.00
Jun 30, 2024 187.00
Mar 31, 2024 504.00
Dec 31, 2023 -312.00
Sep 30, 2023 496.00
Jun 30, 2023 993.00
Mar 31, 2023 -679.00
Dec 31, 2022 373.00
Sep 30, 2022 1,557.00
Jun 30, 2022 -4,375.00
Mar 31, 2022 971.00
Dec 31, 2021 -1,024.00
Sep 30, 2021 -309.00
Jun 30, 2021 3,552.00